Passage Bio to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Feb 26, 2025
PHILADELPHIA, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced management will participate in the following upcoming investor conferences:
Read more at globenewswire.com
